REIMAGINE - Real World EvaluatIon of Mepolizumab in Severe Asthma achievinG on Treatment clinIcal remissioN, a prospEctive Study

Condition:   Asthma Interventions:   Drug: Mepolizumab;   Other: Spirometry Sponsor:   GlaxoSmithKline Not yet recruiting

Source: ClinicalTrials.gov - September 18, 2023 Category: Research Source Type: clinical trials